104 related articles for article (PubMed ID: 22084919)
1. Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults.
Valcke M; Krishnan K
Inhal Toxicol; 2011 Dec; 23(14):863-77. PubMed ID: 22084919
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of the exposure route on the human kinetic adjustment factor.
Valcke M; Krishnan K
Regul Toxicol Pharmacol; 2011 Mar; 59(2):258-69. PubMed ID: 20969910
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the impact of physico-chemical and biochemical characteristics on the human kinetic adjustment factor for systemic toxicants.
Valcke M; Krishnan K
Toxicology; 2011 Aug; 286(1-3):36-47. PubMed ID: 21605617
[TBL] [Abstract][Full Text] [Related]
4. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Nong A; Krishnan K
Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
[TBL] [Abstract][Full Text] [Related]
5. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Valcke M; Haddad S
J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of child/adult differences in hepatic first-pass effect on the human kinetic adjustment factor for ingested toxicants.
Valcke M; Krishnan K
Regul Toxicol Pharmacol; 2013 Feb; 65(1):126-34. PubMed ID: 23200794
[TBL] [Abstract][Full Text] [Related]
7. Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration.
Abraham K; Mielke H; Huisinga W; Gundert-Remy U
Arch Toxicol; 2005 Feb; 79(2):63-73. PubMed ID: 15565428
[TBL] [Abstract][Full Text] [Related]
8. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Nong A; McCarver DG; Hines RN; Krishnan K
Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
Valcke M; Krishnan K
J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the impact of multi-route co-exposures on human variability in toxicokinetics: A case study with binary and quaternary mixtures of volatile drinking water contaminants.
Tohon H; Valcke M; Haddad S
J Appl Toxicol; 2019 Jul; 39(7):974-991. PubMed ID: 30834571
[TBL] [Abstract][Full Text] [Related]
11. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
12. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
[TBL] [Abstract][Full Text] [Related]
13. Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach.
Valcke M; Nong A; Krishnan K
J Toxicol; 2012; 2012():404329. PubMed ID: 22523487
[TBL] [Abstract][Full Text] [Related]
14. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
15. Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene.
Verner MA; McDougall R; Johanson G
Toxicol Lett; 2012 Sep; 213(2):299-304. PubMed ID: 22677344
[TBL] [Abstract][Full Text] [Related]
16. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes.
Haddad S; Tardif GC; Tardif R
J Toxicol Environ Health A; 2006 Dec; 69(23):2095-136. PubMed ID: 17060096
[TBL] [Abstract][Full Text] [Related]
17. Health risk assessment of personal inhalation exposure to volatile organic compounds in Tianjin, China.
Zhou J; You Y; Bai Z; Hu Y; Zhang J; Zhang N
Sci Total Environ; 2011 Jan; 409(3):452-9. PubMed ID: 21078521
[TBL] [Abstract][Full Text] [Related]
18. On the importance of exposure variability to the doses of volatile organic compounds.
Rappaport SM; Kupper LL; Lin YS
Toxicol Sci; 2005 Feb; 83(2):224-36. PubMed ID: 15548640
[TBL] [Abstract][Full Text] [Related]
19. Internal exposure of children by simulated acute inhalation of volatile organic compounds: the influence of chemical properties on the child/adult concentration ratio.
Abraham K; Mielke H; Huisinga W; Gundert-Remy U
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):242-3. PubMed ID: 15733221
[No Abstract] [Full Text] [Related]
20. Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose.
Simmons JE; Evans MV; Boyes WK
J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):927-50. PubMed ID: 16020185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
